Doctors say they have not seen anything like this since the emergence of statins to lower cholesterol. But do we know enough ...
Two in three adults in England are overweight or obese - and 26 per cent of us have learned all we know about treatments like ...
The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply lower Friday, after President-elect Donald Trump named Robert F. Kennedy Jr.
Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...
Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...
A new study has found that the groundbreaking new class of weight loss drugs may not only be good at treating diabetes, but ...
A WOMAN who’s lost a staggering four stone on weight loss injections has hit back at trolls who have slammed her for ...
Ozempic and related GLP-1 drugs have taken Europe and North America by storm and have quickly become the darling of the ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...
Metsera has brought in over $500m in funding in just seven months as it looks to enter the competitive weight loss arena.
Results from the SURMOUNT-1 trial show that weekly injections of tirzepatide could stop the progression from pre-diabetes to ...
After a nurse died after just two weight-loss injections of Mounjaro - which is approved for use on the NHS - here's ...